• For Institutions

    • Corporate Services
    • Developers
  • Download
  • Help
  • About

    • Company Profile
    • License & Regulatory
    • Media coverage
longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Nov18
Mirxes Holding and Walvax Biotechnology Sign Strategic MOU on RNA-focused Medical Cooperation
08:35
Oct28
WALVAX released FY2025 Q3 earnings on October 28 After-Market (BJT), actual revenue CNY 564.6 M (forecast CNY 768.18 M), actual EPS CNY 0.0735 (forecast CNY 0.07)
01:00
WALVAX released FY2025 9 Months Earnings on October 28 After-Market (BJT), actual revenue CNY 1.719 B, actual EPS CNY 0.1004
01:00
Oct21
WALVAX to Release FY2025 Q3 Earnings on October 29 After-Market (BJT), Forecast Revenue CNY 768.18 M, EPS CNY 0.07
01:48
Aug25
WALVAX released FY2025 Semi-Annual earnings on August 25 After-Market (BJT), actual revenue CNY 1.154 B, actual EPS CNY 0.0273
01:00
WALVAX released FY2025 Q2 earnings on August 25 After-Market (BJT), actual revenue CNY 691.95 M (forecast CNY 821.44 M), actual EPS CNY 0.0252 (forecast CNY 0.11)
01:00

Schedules & Filings

Schedules
Filings
Oct28
Earning Release(CST)

FY2025 Q3 Earning Release (CNY) Revenue 564.6 M, Net Income 120.28 M, EPS 0.0735

Aug26
Earning Release(CST)

FY2025 Semi-Annual Earning Release

Aug25
Earning Release(CST)

FY2025 Q2 Earning Release (CNY) Revenue 691.95 M, Net Income 40.51 M, EPS 0.0252

View More

Stock List

Top Gainers
Top Decliners
Northbound Connect
Symbol
Price
%Chg
Change
View More